The connection between thyroid and hormones is one of the most clinically important and most routinely overlooked relationships in endocrinology. Thyroid hormones do not operate in isolation. They regulate the production, conversion, transport, and receptor sensitivity of virtually every other hormone in the body — testosterone, estrogen, progesterone, cortisol, growth hormone, and insulin among them. When thyroid function is suboptimal, the entire hormonal system pays a price that no amount of targeted hormone therapy can fully compensate for.
The frustrating reality is that the standard thyroid test ordered by most general practitioners — a single TSH measurement — misses a significant portion of patients with functional thyroid insufficiency. This article explains what the thyroid does hormonally, why TSH alone is inadequate, how thyroid dysfunction affects every other hormonal axis, and what a complete thyroid evaluation looks like in practice. For context on how to read the full lab panel that catches what TSH misses, see our article on how to read your hormone lab results. According to the National Institutes of Health, subclinical hypothyroidism — thyroid dysfunction that falls within standard reference ranges — affects up to 10% of the general population and up to 20% of women over 60, with meaningful downstream effects on sex hormone function, metabolism, and quality of life.
Quick answer
Thyroid hormones regulate SHBG (which determines how much testosterone is biologically available), aromatase activity (which converts testosterone to estrogen), cortisol metabolism, GH sensitivity, and insulin function. A standard TSH-only panel misses free T3 deficiency, poor T4-to-T3 conversion, and Hashimoto’s autoimmune thyroiditis — all of which produce meaningful hormonal disruption despite a “normal” TSH. A complete thyroid panel is a prerequisite for any meaningful hormonal evaluation.
What Thyroid Hormones Actually Do
The thyroid gland produces two primary hormones: thyroxine (T4) and triiodothyronine (T3). T4 is the storage form — abundant, stable, and largely inactive until converted to T3 in peripheral tissues, primarily the liver, kidney, and gut. T3 is the metabolically active form that enters cells, binds to thyroid hormone receptors in the nucleus, and regulates gene expression. Every cell in the body has thyroid hormone receptors, which is why thyroid dysfunction produces such a wide and apparently unrelated range of symptoms.
TSH (thyroid-stimulating hormone) is produced by the pituitary gland and signals the thyroid to produce more T4 and T3. Elevated TSH indicates the pituitary is working harder to stimulate an underperforming thyroid. Suppressed TSH indicates the pituitary is pulling back because thyroid hormone levels are adequate or elevated. TSH is a useful screening tool but it is an indirect marker — it measures the pituitary’s perception of thyroid hormone status, not the actual T3 concentration available to cells. These are not the same thing.
The T4-to-T3 conversion problem
Approximately 80% of circulating T3 comes not from direct thyroid secretion but from peripheral conversion of T4 to T3 by deiodinase enzymes. This conversion is impaired by chronic stress (elevated cortisol), selenium deficiency, gut inflammation, certain medications (beta-blockers, amiodarone, lithium), heavy metal toxicity, and caloric restriction. A patient can have normal T4 and normal TSH while producing severely inadequate amounts of active T3 — a pattern that is entirely invisible on a TSH-only panel and that produces full hypothyroid symptomatology despite a “normal” lab result.
Why TSH Alone Is Not Enough: The Case for a Full Panel
The standard primary care approach to thyroid testing measures only TSH, and sometimes adds total T4 if TSH is abnormal. This approach misses three clinically important conditions that affect a significant portion of patients presenting with fatigue, weight gain, low libido, brain fog, and hormonal symptoms.
Free T3 deficiency with normal TSH
The most common missed thyroid diagnosis. A patient converts T4 to T3 inefficiently, producing chronically low intracellular T3 despite adequate T4 and normal TSH. Symptoms are identical to clinical hypothyroidism: persistent fatigue, weight gain, cold intolerance, constipation, hair thinning, depression, and cognitive slowing. The pattern is confirmed only with a free T3 measurement alongside free T4 and TSH.
Reverse T3 dominance
Under stress, chronic illness, caloric restriction, or inflammation, the body can divert T4 conversion away from active T3 toward reverse T3 (rT3) — an inactive isomer that occupies T3 receptors without activating them. The result is functional hypothyroidism even when free T3 appears adequate on a lab report, because the available T3 receptors are being blocked by rT3. Measuring rT3 and calculating the free T3-to-rT3 ratio reveals this pattern. For context on how caloric restriction drives this process, see our article on why calorie restriction fails.
Hashimoto’s thyroiditis with normal TSH
Hashimoto’s is an autoimmune condition in which the immune system attacks the thyroid gland. It is the most common cause of hypothyroidism in developed countries and is significantly underdiagnosed because TPO antibodies (the diagnostic marker) are not tested on standard panels. A patient with Hashimoto’s can have normal TSH for years or decades while the autoimmune attack progressively destroys thyroid tissue. Symptoms during this phase are episodic and variable — alternating between hypothyroid and hyperthyroid presentations depending on how much thyroid tissue is being destroyed and how much thyroid hormone is being released into circulation. This Hashimoto’s “swings” pattern is frequently misattributed to anxiety, perimenopause, or stress without the antibody testing that would reveal the autoimmune cause.
Complete Thyroid Panel: What to Test and Why
Marker
Standard range
Optimal target
What it reveals
TSH
0.5–4.5 mIU/L
1.0–2.5 mIU/L
Pituitary signal to thyroid. Useful screen but indirect. Misses conversion and receptor problems.
Free T4
0.8–1.8 ng/dL
1.1–1.5 ng/dL
Available T4 for conversion. Low free T4 with normal TSH = thyroid underproduction or pituitary insensitivity.
Free T3
2.3–4.2 pg/mL
3.2–4.2 pg/mL
Active thyroid hormone at tissue level. Most important marker for symptom correlation and metabolic rate.
Reverse T3
9.2–24.1 ng/dL
Below 15 ng/dL
Inactive T3 competitor. Elevated in stress, illness, caloric restriction. Blocks T3 receptors.
TPO Antibodies
Below 35 IU/mL
Below 35 IU/mL
Autoimmune attack on thyroid (Hashimoto’s). Present for years before TSH becomes abnormal.
Thyroglobulin Antibodies
Below 1 IU/mL
Below 1 IU/mL
Second Hashimoto’s marker. Some Hashimoto’s patients have elevated TgAb without elevated TPO.
A TSH-only panel reveals only one of these six markers. Testing all six costs modestly more and reveals the full picture that treatment decisions actually require.
How Thyroid Dysfunction Affects Testosterone
The thyroid-testosterone connection operates through several simultaneous mechanisms, which is why men with undiagnosed or undertreated hypothyroidism frequently present with low testosterone symptoms even when their testosterone levels appear normal on a standard panel.
Thyroid hormones regulate SHBG
Sex hormone-binding globulin (SHBG) — the protein that binds testosterone and renders it biologically inactive — is directly regulated by thyroid hormone levels. Hypothyroidism lowers SHBG, which sounds favorable (lower SHBG means more free testosterone) but is actually not the full picture. Hyperthyroidism dramatically raises SHBG, reducing free testosterone even when total testosterone is normal or elevated. This is one reason why hyperthyroid men frequently experience low libido and sexual dysfunction despite not having classically “low” testosterone: their total testosterone may be high, but elevated SHBG means almost none of it is biologically available. Free testosterone measurement, alongside SHBG, is essential for understanding the functional testosterone status in any patient with thyroid abnormalities. For more on how SHBG affects testosterone interpretation, see our article on understanding testosterone deficiency.
Thyroid hormones affect Leydig cell function
Thyroid hormone receptors are present in testicular Leydig cells — the primary site of testosterone production. Adequate T3 is required for normal Leydig cell function and testosterone biosynthesis. Hypothyroidism impairs Leydig cell response to LH stimulation, reducing testosterone output independently of LH levels. This creates a secondary hypogonadism pattern where LH is normal but testosterone production is blunted — a pattern that may be misinterpreted as primary testicular dysfunction if the thyroid context is missed.
Thyroid dysfunction affects aromatase activity
Aromatase, the enzyme that converts testosterone to estrogen, is regulated in part by thyroid hormones. Hypothyroidism can increase aromatase activity in adipose tissue, accelerating testosterone-to-estrogen conversion. In men who already have elevated body fat — another consequence of hypothyroidism — this creates a compounding cycle: thyroid dysfunction promotes fat gain, fat gain increases aromatase, aromatase reduces testosterone, low testosterone increases fat. This cycle is described in detail in our article on low testosterone and belly fat.
Clinical note: treat thyroid before TRT
Men presenting with low testosterone alongside thyroid dysfunction should have thyroid status optimized before or alongside TRT initiation, not after. Starting TRT in a hypothyroid man without addressing the thyroid leaves the underlying suppression of Leydig cell function and the elevated aromatase activity in place. In some cases, thyroid optimization alone restores testosterone to adequate levels without TRT. Prescribing TRT without first checking a full thyroid panel is incomplete clinical practice for this reason.
Thyroid and Estrogen: The Female Hormone Connection
Thyroid disease is significantly more common in women than in men — approximately 7 to 10 times more prevalent — and the thyroid-estrogen interaction explains much of this disparity. Estrogen and thyroid hormones interact bidirectionally in ways that amplify both deficiencies when either is present.
Estrogen raises thyroid-binding globulin (TBG), the protein that carries T4 and T3 in the bloodstream. Higher TBG means more thyroid hormone is bound and less is free and active. This is why oral estrogen therapy (but not transdermal estradiol, which does not raise TBG via the same hepatic mechanism) frequently worsens functional thyroid status in women. Women transitioning to oral HRT who develop new fatigue, weight gain, or cognitive slowing should have their free T3 checked, as the estrogen-TBG elevation may have shifted them into functional hypothyroidism despite unchanged thyroid gland function.
Conversely, hypothyroidism disrupts the menstrual cycle by affecting LH and FSH pulsatility and by increasing prolactin (which thyroid-stimulating hormone structurally resembles — elevated TRH from hypothyroidism also elevates prolactin, suppressing GnRH and sex hormones). Women with unexplained menstrual irregularity, fertility difficulties, or recurrent miscarriage should have a complete thyroid panel including antibodies as part of their evaluation. For women in perimenopause experiencing a worsening of symptoms despite HRT, thyroid reassessment is essential before attributing all symptoms to ovarian hormone decline. For more on the full perimenopausal hormonal picture, see our article on perimenopause and hormone therapy.
Thyroid, Cortisol, and the Stress-Hormone Cascade
The thyroid-cortisol relationship is bidirectional and clinically important. Chronic cortisol elevation — from psychological stress, sleep deprivation, or chronic illness — impairs T4-to-T3 conversion by suppressing deiodinase enzyme activity and simultaneously increases reverse T3 production. The practical consequence is that patients under chronic stress may develop functional hypothyroidism not because their thyroid gland is failing but because elevated cortisol is preventing their available T4 from being converted to active T3.
In the opposite direction, hypothyroidism impairs cortisol clearance from the body, leading to cortisol accumulation and elevated cortisol activity despite potentially normal cortisol production. This creates a situation where hypothyroid patients may present with elevated afternoon cortisol on lab testing — which can be misinterpreted as “stress-related” without recognizing the thyroid insufficiency driving the cortisol metabolism problem. For a detailed explanation of how cortisol drives metabolic and hormonal dysfunction when it becomes chronically elevated, see our article on the cortisol and belly fat connection.
The dangerous misdiagnosis pattern
A common clinical trap: a patient presents with fatigue, weight gain, depression, cognitive slowing, low libido, and poor sleep. TSH is checked and comes back at 2.8 mIU/L — technically normal. The patient is told their thyroid is fine and referred for psychiatric evaluation or attributed to “stress.” But free T3 is 2.4 pg/mL (low normal), reverse T3 is elevated at 22 ng/dL, and TPO antibodies are 180 IU/mL (significantly elevated — Hashimoto’s). The entire symptom picture has an identifiable thyroid-autoimmune cause that a TSH-only panel completely missed. This scenario is not unusual. It is one of the most common missed diagnoses in hormone medicine.
Thyroid and Growth Hormone: The Overlooked Pair
Thyroid hormones and growth hormone share overlapping functions in regulating metabolism, body composition, and tissue repair — and they are mutually dependent. Adequate thyroid hormone is required for GH to produce its effects on peripheral tissue. Hypothyroid patients show blunted IGF-1 response to GH stimulation, meaning they do not get the full benefit of their existing GH pulses or, if on GH therapy, of their prescribed treatment.
Conversely, GH promotes T4-to-T3 conversion by upregulating deiodinase enzyme activity in peripheral tissues. Adults with GH deficiency frequently show reduced free T3 and increased reverse T3 despite normal thyroid gland function — a pattern that contributes to the metabolic slowing, fatigue, and body composition changes of GH deficiency and that partially reverses with GH replacement. For patients on HGH therapy who have a sluggish response, thyroid status — particularly free T3 — should be evaluated as a potential limiting factor. For Sermorelin patients, the same consideration applies. See our article on what Sermorelin is and how it works for context on how GH stimulation therapy interacts with the broader hormonal system.
Thyroid and Insulin Resistance: The Metabolic Connection
Thyroid hormones regulate glucose metabolism at multiple levels: they influence insulin receptor sensitivity, hepatic glucose production, and the rate at which cells use glucose for energy. Hypothyroidism reduces insulin sensitivity and slows glucose uptake in peripheral tissues, creating a pattern that resembles insulin resistance. Patients with undiagnosed or undertreated hypothyroidism who are evaluated for insulin resistance or prediabetes may be receiving treatment for a metabolic condition whose primary driver is thyroid insufficiency.
The practical implication is relevant for patients on GLP-1 therapy for metabolic dysfunction or weight resistance. If hypothyroidism is contributing to the insulin resistance that GLP-1 is being used to treat, optimizing thyroid function alongside GLP-1 therapy produces significantly better metabolic outcomes than GLP-1 alone. For a detailed breakdown of how hormonal factors drive weight resistance, see our article on why calorie restriction fails when hormones are off.
Tip: optimize thyroid before other hormone interventions
Thyroid optimization should be sequenced before or alongside other hormonal interventions for a specific reason: thyroid hormones affect the receptor sensitivity and metabolism of every other hormone. A patient who starts testosterone therapy, HGH, or bioidentical estrogen with unaddressed hypothyroidism will get an attenuated response because the hormonal substrate all of these therapies depend on — adequate T3 at the receptor level — is impaired. Achieving adequate free T3 first creates the optimal foundation for all other hormonal interventions to work at full capacity. For the full sequencing discussion, see our article on what to expect at your first hormone therapy appointment.
Frequently Asked Questions
My TSH is normal but I still feel terrible. Could it be my thyroid?
Yes. A normal TSH does not rule out thyroid dysfunction. Three common patterns produce thyroid symptoms with normal TSH: low free T3 from poor T4-to-T3 conversion, elevated reverse T3 blocking T3 receptors, and Hashimoto’s thyroiditis producing episodic symptoms while TSH is still within range. A full thyroid panel including free T3, free T4, reverse T3, TPO antibodies, and thyroglobulin antibodies is required to rule out these conditions. The standard TSH-only test cannot do this.
Can hypothyroidism cause low testosterone in men?
Yes, through multiple mechanisms. Hypothyroidism impairs Leydig cell testosterone production, disrupts the HPG axis through elevated prolactin (driven by elevated TRH in hypothyroidism), increases aromatase activity in adipose tissue, and promotes weight gain that further suppresses testosterone. Men with borderline or confirmed low testosterone should have a full thyroid panel before TRT is initiated. In some cases, thyroid optimization restores testosterone to adequate levels without testosterone replacement.
What is Hashimoto’s thyroiditis and how is it different from regular hypothyroidism?
Hashimoto’s is an autoimmune condition where the immune system produces antibodies against thyroid tissue, gradually destroying it. Standard hypothyroidism refers to the thyroid gland failing to produce adequate hormones for any reason. Hashimoto’s is the most common cause of hypothyroidism in developed countries, but the two are managed somewhat differently. Hashimoto’s requires monitoring for the antibody-driven fluctuations, consideration of dietary and immune factors (gluten sensitivity, selenium status), and attention to the episodic symptoms during active autoimmune phases. TPO antibodies are elevated in Hashimoto’s and are the diagnostic test, not TSH.
Does thyroid dysfunction affect women more than men?
Yes, significantly. Thyroid disease is 7 to 10 times more common in women than men. The reasons include the interaction between estrogen and thyroid function (estrogen fluctuations during menstrual cycling, pregnancy, and menopause all stress the thyroid system), the higher baseline rate of autoimmune disease in women, and genetic factors in immune regulation. Postpartum thyroiditis — thyroid dysfunction following childbirth — is almost exclusively a female condition and affects 5 to 10% of women. Any woman presenting with fatigue, weight gain, hair loss, or mood changes in the context of hormonal shifts deserves a complete thyroid evaluation.
Can stress alone cause thyroid dysfunction?
Stress does not cause the thyroid gland to fail, but it produces functional thyroid insufficiency through two mechanisms: elevated cortisol impairs T4-to-T3 conversion by suppressing deiodinase enzymes, and elevated cortisol increases reverse T3 production, blocking T3 receptors. The clinical consequence is identical to mild hypothyroidism in terms of symptoms and metabolic effects, even though the thyroid gland itself is functioning normally. This stress-induced functional hypothyroidism typically reverses when the cortisol burden is reduced, but it can persist for months during chronic stress and may transition to true autoimmune thyroid disease in genetically predisposed individuals.
Is levothyroxine (T4-only therapy) always sufficient for hypothyroidism?
For many patients, yes. Levothyroxine replaces T4, which peripheral tissues convert to active T3. For patients who convert well, this is adequate. However, 10 to 15% of patients on levothyroxine report persistent symptoms despite normal TSH on treatment. Research suggests this subset has suboptimal T4-to-T3 conversion and may benefit from combination T4-T3 therapy (levothyroxine plus liothyronine) or desiccated thyroid extract (which naturally contains both T4 and T3). Free T3 monitoring on levothyroxine therapy reveals when conversion is inadequate — another reason the full panel matters even for patients already being treated for thyroid disease.
What nutrients support thyroid function?
Iodine is required for thyroid hormone synthesis — severe deficiency causes goiter and hypothyroidism, though iodine deficiency is rare in developed countries with iodized salt. Selenium is critical for deiodinase enzyme function and T4-to-T3 conversion, and selenium deficiency is more common than often appreciated. Zinc is required for thyroid hormone receptor function. Iron deficiency impairs thyroid peroxidase activity (the enzyme that synthesizes thyroid hormones). Vitamin D deficiency is associated with higher rates of Hashimoto’s and other autoimmune thyroid conditions. These nutrient factors should be evaluated alongside the thyroid panel itself, particularly in patients with Hashimoto’s or poor conversion.
Should thyroid be checked before starting hormone therapy?
Yes, absolutely. Thyroid status should be part of every baseline hormone evaluation because thyroid dysfunction affects the metabolism, receptor sensitivity, and clinical response to all other hormone therapies. Starting testosterone therapy in a hypothyroid man, or HRT in a hypothyroid woman, without addressing the thyroid will produce an attenuated or confusing clinical response. The baseline panel at VitalBalance includes a full thyroid assessment alongside sex hormones, IGF-1, cortisol, and metabolic markers for exactly this reason. See our article on your first hormone therapy appointment for the complete baseline evaluation overview.
Our specialists run a complete thyroid panel — TSH, free T3, free T4, reverse T3, and antibodies — alongside your full hormone evaluation. We interpret results in the context of your symptoms and design a treatment plan that addresses the full hormonal picture.
This article is for informational and educational purposes only. It does not constitute medical advice, a diagnosis, or a treatment recommendation. Thyroid disorders require evaluation and management by a licensed healthcare provider. Reference ranges and optimal targets cited reflect clinical practice standards and may vary between laboratories and individual clinical contexts. Hashimoto’s thyroiditis and other autoimmune thyroid conditions require specialist evaluation. If you are experiencing symptoms associated with thyroid dysfunction or hormonal imbalance, consult a licensed provider for appropriate evaluation and testing.
